Sign inGet started

SLNO

SOLENO THERAPEUTICS INCCIK 1484565 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
42

AI insights for SLNO PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for SLNO
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Huang Michael F.Sr. VP of Clinical Development24$0$1.21M2026-05-18
Joshi ManherChief Development Officer7$0$02026-05-18
Fulk JenniferCHIEF FINANCIAL OFFICER4$0$02026-05-18
Norrett KevinChief Business Officer7$0$02026-05-18
Hirano Patricia CSee Remarks92$0$13.39M2026-05-18
Sinclair AndrewDirector25$15.78M$02026-05-18
Volck BirgitteDirector26$0$02026-05-18
Manning MeredithChief Commercial Officer24$0$3.27M2026-05-18
Bir Dawn CarterDirector3$0$02026-05-18
Yen KristenVice President, Clinical Opera81$0$9.70M2026-05-18
Anish BhatnagarSee Remarks96$0$67.89M2026-05-18
Pauls MatthewDirector8$0$424.8K2026-05-18
Hahn Mark WDirector2$0$02026-05-18
Mackaness James HChief Financial Officer76$20.0K$10.42M2026-01-21
Harris William GDirector28$0$4.3K2025-06-05
Vivo Opportunity Fund Holdings, L.P.10% Owner9$0$176.15M2025-03-28
Vivo Opportunity, LLC10% Owner3$0$49.21M2024-08-29
Urbanski Raymond W.CHIEF DEVELOPMENT OFFICER1$0$02024-08-13
MARIO ERNESTDirector, 10% Owner42$0$02024-06-06
Carlyle Holdings I GP Sub L.L.C.10% Owner3$0$02023-09-28
PERCEPTIVE ADVISORS LLC10% Owner22$21.37M$02023-09-28
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD10% Owner3$188.2K$02023-06-01
Melincoff Gwen ADirector9$15.4K$02023-05-26
EDELMAN JOSEPH10% Owner3$449.8K$02023-05-26
Carlyle Holdings I L.P.10% Owner2$1.26M$02023-05-08
SCHULER JACK W10% Owner118$22.91M$5.01M2022-12-09
Abingworth LLP10% Owner9$8.26M$02022-03-29
COLLINSON STUART JDirector, 10% Owner8$0$02020-07-31
ORACLE PARTNERS LP10% Owner4$122.1K$677.9K2020-06-08
Vivo Ventures V, LLC10% Owner5$0$83.1K2019-12-02
Vivo Ventures V Affiliates Fund, L.P.10% Owner16$2.00M$294.6K2019-11-25
Vivo Ventures Fund V, L.P.10% Owner7$0$602.9K2019-11-20
BIOASIA INVESTMENTS IV LLC10% Owner4$0$174.9K2019-05-20
FEINBERG LARRY N10% Owner16$2.25M$02019-03-14
Wolter JonathanChief Financial Officer2$0$02019-01-24
TECHNOLOGY PARTNERS AFFILIATES VII LP10% Owner10$0$46.1K2018-09-13
Glasheen James WalterDirector, 10% Owner4$0$02018-06-11
SHAH MAHENDRADirector4$0$02018-06-11
DALAL RAJENDirector4$0$02018-06-11
Kirnon StephenDirector3$0$02018-02-05
ENGLEMAN EDGARDirector, 10% Owner7$2.00M$02018-02-05
ENGELSEN STEINAR JDirector3$0$02018-02-05

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Anish BhatnagarCHIEF EXECUTIVE OFFICER D To issuer deriv2026-05-182026-05-18100,000— $00SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER D To issuer deriv2026-05-182026-05-18200,753— $00SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER D To issuer deriv2026-05-182026-05-1852,709— $00SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER D To issuer deriv2026-05-182026-05-1873,333— $00SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER D To issuer deriv2026-05-182026-05-188,473— $00SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER D To issuer deriv2026-05-182026-05-1835,000— $00SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER D To issuer deriv2026-05-182026-05-1823,332— $00SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER D To issuer deriv2026-05-182026-05-1860— $00SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER D To issuer deriv2026-05-182026-05-1822,452— $00SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER D To issuer deriv2026-05-182026-05-18131,400— $00SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER D To issuer deriv2026-05-182026-05-18115,600— $00SEC↗
Fulk JenniferCHIEF FINANCIAL OFFICER D To issuer deriv2026-05-182026-05-1867,660— $00SEC↗
Hirano Patricia CSEE REMARKS D To issuer deriv2026-05-182026-05-1816,000— $00SEC↗
Hirano Patricia CSEE REMARKS D To issuer deriv2026-05-182026-05-1849,262— $00SEC↗
Hirano Patricia CSEE REMARKS D To issuer deriv2026-05-182026-05-1811,667— $00SEC↗
Hirano Patricia CSEE REMARKS D To issuer deriv2026-05-182026-05-181,333— $00SEC↗
Hirano Patricia CSEE REMARKS D To issuer deriv2026-05-182026-05-1818,842— $00SEC↗
Hirano Patricia CSEE REMARKS D To issuer deriv2026-05-182026-05-182,333— $00SEC↗
Hirano Patricia CSEE REMARKS D To issuer deriv2026-05-182026-05-1813,800— $00SEC↗
Hirano Patricia CSEE REMARKS D To issuer deriv2026-05-182026-05-1811,900— $00SEC↗
Hirano Patricia CSEE REMARKS D To issuer deriv2026-05-182026-05-182,445— $00SEC↗
Huang Michael F.Sr. VP of Clinical Developme D To issuer deriv2026-05-182026-05-1813,800— $00SEC↗
Huang Michael F.Sr. VP of Clinical Developme D To issuer deriv2026-05-182026-05-18110,000— $00SEC↗
Huang Michael F.Sr. VP of Clinical Developme D To issuer deriv2026-05-182026-05-1811,900— $00SEC↗
Joshi ManherChief Development Officer D To issuer deriv2026-05-182026-05-184,700— $00SEC↗
Joshi ManherChief Development Officer D To issuer deriv2026-05-182026-05-1872,321— $00SEC↗
Manning MeredithChief Commercial Officer D To issuer deriv2026-05-182026-05-1832,800— $00SEC↗
Manning MeredithChief Commercial Officer D To issuer deriv2026-05-182026-05-1829,200— $00SEC↗
Manning MeredithChief Commercial Officer D To issuer deriv2026-05-182026-05-1891,000— $00SEC↗
Norrett KevinChief Business Officer D To issuer deriv2026-05-182026-05-1864,286— $00SEC↗
Norrett KevinChief Business Officer D To issuer deriv2026-05-182026-05-184,000— $00SEC↗
Pauls MatthewDirector D To issuer deriv2026-05-182026-05-189,063— $00SEC↗
Sinclair AndrewDirector D To issuer deriv2026-05-182026-05-182,666— $00SEC↗
Sinclair AndrewDirector D To issuer deriv2026-05-182026-05-18635— $00SEC↗
Sinclair AndrewDirector D To issuer deriv2026-05-182026-05-18823— $00SEC↗
Sinclair AndrewDirector D To issuer deriv2026-05-182026-05-181,333— $00SEC↗
Sinclair AndrewDirector D To issuer deriv2026-05-182026-05-182,666— $00SEC↗
Sinclair AndrewDirector D To issuer deriv2026-05-182026-05-182,666— $00SEC↗
Sinclair AndrewDirector D To issuer deriv2026-05-182026-05-182,124— $00SEC↗
Sinclair AndrewDirector D To issuer deriv2026-05-182026-05-1810,000— $00SEC↗
Volck BirgitteDirector D To issuer deriv2026-05-182026-05-181,333— $00SEC↗
Volck BirgitteDirector D To issuer deriv2026-05-182026-05-18635— $00SEC↗
Volck BirgitteDirector D To issuer deriv2026-05-182026-05-182,666— $00SEC↗
Volck BirgitteDirector D To issuer deriv2026-05-182026-05-182,124— $00SEC↗
Volck BirgitteDirector D To issuer deriv2026-05-182026-05-182,666— $00SEC↗
Volck BirgitteDirector D To issuer deriv2026-05-182026-05-1810,000— $00SEC↗
Volck BirgitteDirector D To issuer deriv2026-05-182026-05-182,666— $00SEC↗
Yen KristenSEE REMARKS D To issuer deriv2026-05-182026-05-184,000— $00SEC↗
Yen KristenSEE REMARKS D To issuer deriv2026-05-182026-05-181,741— $00SEC↗
Yen KristenSEE REMARKS D To issuer deriv2026-05-182026-05-184,999— $00SEC↗
Yen KristenSEE REMARKS D To issuer deriv2026-05-182026-05-18666— $00SEC↗
Yen KristenSEE REMARKS D To issuer deriv2026-05-182026-05-1818,800— $00SEC↗
Yen KristenSEE REMARKS D To issuer deriv2026-05-182026-05-182,445— $00SEC↗
Yen KristenSEE REMARKS D To issuer deriv2026-05-182026-05-1811,667— $00SEC↗
Yen KristenSEE REMARKS D To issuer deriv2026-05-182026-05-1855,392— $00SEC↗
Yen KristenSEE REMARKS D To issuer deriv2026-05-182026-05-1816,000— $00SEC↗
Yen KristenSEE REMARKS D To issuer deriv2026-05-182026-05-1813,800— $00SEC↗
Yen KristenSEE REMARKS D To issuer deriv2026-05-182026-05-1811,900— $00SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER D To issuer2026-05-182026-05-18583,656— $00SEC↗
Bir Dawn CarterDirector D To issuer2026-05-182026-05-1816,991— $00SEC↗
Fulk JenniferCHIEF FINANCIAL OFFICER D To issuer2026-05-182026-05-1839,200— $00SEC↗
Hahn Mark WDirector D To issuer2026-05-182026-05-1810,046— $00SEC↗
Hirano Patricia CSEE REMARKS D To issuer2026-05-182026-05-1822,702— $00SEC↗
Huang Michael F.Sr. VP of Clinical Developme D To issuer2026-05-182026-05-1839,823— $00SEC↗
Joshi ManherChief Development Officer D To issuer2026-05-182026-05-1820,171— $00SEC↗
Manning MeredithChief Commercial Officer D To issuer2026-05-182026-05-1864,507— $00SEC↗
Norrett KevinChief Business Officer D To issuer2026-05-182026-05-1817,786— $00SEC↗
Pauls MatthewDirector D To issuer2026-05-182026-05-1810,491— $00SEC↗
Sinclair AndrewDirector D To issuer2026-05-182026-05-1810,491— $00SEC↗
Volck BirgitteDirector D To issuer2026-05-182026-05-1817,536— $00SEC↗
Yen KristenSEE REMARKS D To issuer2026-05-182026-05-1837,639— $00SEC↗
Huang Michael F.Sr. VP of Clinical Developme S Sale2026-03-272026-03-311,838$31.04 $57.1K40,311SEC↗
Huang Michael F.Sr. VP of Clinical Developme S Sale2026-03-272026-03-31488$31.72 $15.5K39,823SEC↗
Huang Michael F.Sr. VP of Clinical Developme S Sale2026-03-272026-03-314,256$30.04 $127.9K42,149SEC↗
Manning MeredithChief Commercial Officer S Sale2026-03-272026-03-314,864$30.04 $146.1K67,165SEC↗
Manning MeredithChief Commercial Officer S Sale2026-03-272026-03-312,100$31.04 $65.2K65,065SEC↗
Manning MeredithChief Commercial Officer S Sale2026-03-272026-03-31558$31.72 $17.7K64,507SEC↗
Fulk JenniferCHIEF FINANCIAL OFFICER M Exercise deriv2026-03-022026-03-0467,660— $067,660SEC↗
Fulk JenniferCHIEF FINANCIAL OFFICER A Award2026-03-022026-03-0439,200— $039,200SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER A Award deriv2026-01-212026-01-23131,400— $0131,400SEC↗
Hirano Patricia CSEE REMARKS A Award deriv2026-01-212026-01-2311,900— $011,900SEC↗
Huang Michael F.Sr. VP of Clinical Developme A Award deriv2026-01-212026-01-2311,900— $011,900SEC↗
Joshi ManherChief Development Officer A Award deriv2026-01-212026-01-234,700— $04,700SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER A Award deriv2026-01-212026-01-2332,800— $032,800SEC↗
Manning MeredithChief Commercial Officer A Award deriv2026-01-212026-01-2332,800— $032,800SEC↗
Norrett KevinChief Business Officer A Award deriv2026-01-212026-01-234,000— $04,000SEC↗
Yen KristenSEE REMARKS A Award deriv2026-01-212026-01-2311,900— $011,900SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER A Award2026-01-212026-01-23114,200— $0583,656SEC↗
Hirano Patricia CSEE REMARKS A Award2026-01-212026-01-2310,400— $022,702SEC↗
Huang Michael F.Sr. VP of Clinical Developme A Award2026-01-212026-01-2310,400— $046,405SEC↗
Joshi ManherChief Development Officer A Award2026-01-212026-01-234,100— $020,171SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER A Award2026-01-212026-01-2328,600— $0131,763SEC↗
Manning MeredithChief Commercial Officer A Award2026-01-212026-01-2328,600— $072,029SEC↗
Norrett KevinChief Business Officer A Award2026-01-212026-01-233,500— $017,786SEC↗
Yen KristenSEE REMARKS A Award2026-01-212026-01-2310,400— $037,639SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER G Gift2025-12-152025-12-17100,000— $0469,456SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER F Tax w/h2025-12-152025-12-177,620$49.95 $380.6K569,456SEC↗
Hirano Patricia CSEE REMARKS F Tax w/h2025-12-152025-12-17904$49.95 $45.2K12,302SEC↗
Huang Michael F.Sr. VP of Clinical Developme F Tax w/h2025-12-152025-12-17812$49.95 $40.6K36,005SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER F Tax w/h2025-12-152025-12-172,013$49.95 $100.5K103,163SEC↗
Manning MeredithChief Commercial Officer F Tax w/h2025-12-152025-12-171,922$49.95 $96.0K43,429SEC↗
Yen KristenSEE REMARKS F Tax w/h2025-12-152025-12-17904$49.95 $45.2K27,239SEC↗
Norrett KevinChief Business Officer M Exercise deriv2025-11-172025-11-1964,286— $064,286SEC↗
Norrett KevinChief Business Officer A Award2025-11-172025-11-1914,286— $014,286SEC↗
Joshi ManherChief Development Officer M Exercise deriv2025-11-102025-11-1272,321— $072,321SEC↗
Joshi ManherChief Development Officer A Award2025-11-102025-11-1216,071— $016,071SEC↗
Hahn Mark WDirector A Award2025-10-132025-10-1410,046— $010,046SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-07-012025-07-033,830$82.76 $317.0K13,206SEC↗
Hirano Patricia CSEE REMARKS M Exercise deriv2025-06-242025-06-26266— $00SEC↗
Hirano Patricia CSEE REMARKS M Exercise2025-06-242025-06-26266$44.25 $11.8K17,302SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-06-242025-06-26266$84.25 $22.4K17,036SEC↗
Bir Dawn CarterDirector A Award2025-06-052025-06-093,991— $016,991SEC↗
Harris William GDirector A Award2025-06-052025-06-093,991— $019,392SEC↗
Pauls MatthewDirector A Award2025-06-052025-06-093,991— $010,491SEC↗
Sinclair AndrewDirector A Award2025-06-052025-06-093,991— $010,491SEC↗
Volck BirgitteDirector A Award2025-06-052025-06-093,991— $017,536SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-04-012025-04-023,782$70.11 $265.2K27,036SEC↗
Hirano Patricia CSEE REMARKS M Exercise deriv2025-03-282025-03-312,691— $018,842SEC↗
Pauls MatthewDirector M Exercise deriv2025-03-282025-03-315,937— $09,063SEC↗
Vivo Opportunity Fund Holdings10% Owner S Sale2025-03-282025-03-28333,557$70.60 $23.55M4,458,294SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-03-282025-03-312,691$73.60 $198.1K30,818SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-03-282025-03-319,253$69.52 $643.3K33,509SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-03-282025-03-3112,324$68.92 $849.4K42,762SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-03-282025-03-313,394$67.46 $229.0K55,086SEC↗
Hirano Patricia CSEE REMARKS M Exercise2025-03-282025-03-312,691$33.60 $90.4K58,480SEC↗
Pauls MatthewDirector S Sale2025-03-282025-03-315,937$71.55 $424.8K6,500SEC↗
Pauls MatthewDirector M Exercise2025-03-282025-03-315,937$4.60 $27.3K12,437SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER M Exercise deriv2025-03-272025-03-31281,053— $0200,753SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER M Exercise deriv2025-03-272025-03-3126,606— $060SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER M Exercise deriv2025-03-272025-03-3116,666— $00SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER M Exercise deriv2025-03-272025-03-31105,000— $035,000SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER M Exercise deriv2025-03-272025-03-3132,193— $08,473SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER M Exercise deriv2025-03-272025-03-3162,291— $052,709SEC↗
Hirano Patricia CSEE REMARKS M Exercise deriv2025-03-272025-03-316,000— $00SEC↗
Hirano Patricia CSEE REMARKS M Exercise deriv2025-03-272025-03-314,400— $00SEC↗
Hirano Patricia CSEE REMARKS M Exercise deriv2025-03-272025-03-314,888— $02,445SEC↗
Hirano Patricia CSEE REMARKS M Exercise deriv2025-03-272025-03-3113,333— $00SEC↗
Hirano Patricia CSEE REMARKS M Exercise deriv2025-03-272025-03-318,333— $011,667SEC↗
Hirano Patricia CSEE REMARKS M Exercise deriv2025-03-272025-03-3135,186— $049,262SEC↗
Huang Michael F.Sr. VP of Clinical Developme M Exercise deriv2025-03-272025-03-3110,000— $0110,000SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER M Exercise deriv2025-03-272025-03-3115,000— $015,000SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER M Exercise deriv2025-03-272025-03-3120,000— $00SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER M Exercise deriv2025-03-272025-03-315,000— $00SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER M Exercise deriv2025-03-272025-03-3120,000— $067,251SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER M Exercise deriv2025-03-272025-03-3110,000— $03,000SEC↗
Manning MeredithChief Commercial Officer M Exercise deriv2025-03-272025-03-3137,000— $091,000SEC↗
Yen KristenSEE REMARKS M Exercise deriv2025-03-272025-03-3132,000— $055,392SEC↗
Yen KristenSEE REMARKS M Exercise deriv2025-03-272025-03-313,750— $011,667SEC↗
Yen KristenSEE REMARKS M Exercise deriv2025-03-272025-03-314,888— $02,445SEC↗
Vivo Opportunity Fund Holdings10% Owner S Sale2025-03-272025-03-281,100,000$67.80 $74.58M4,791,851SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2025-03-272025-03-3155,234$68.79 $3.80M617,861SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2025-03-272025-03-3123,095$66.79 $1.54M715,084SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2025-03-272025-03-31199,226$69.30 $13.81M577,076SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2025-03-272025-03-318,423$67.37 $567.5K776,302SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2025-03-272025-03-31209,689$66.33 $13.91M784,725SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2025-03-272025-03-31106,471$65.81 $7.01M994,414SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER M Exercise2025-03-272025-03-31281,053$5.25 $1.48M1,100,885SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER M Exercise2025-03-272025-03-3162,291$2.41 $150.1K819,832SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER M Exercise2025-03-272025-03-3132,193$5.10 $164.2K757,541SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER M Exercise2025-03-272025-03-31105,000$33.60 $3.53M725,348SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER M Exercise2025-03-272025-03-3116,666$25.05 $417.5K620,348SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER M Exercise2025-03-272025-03-3126,606$24.00 $638.5K603,682SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2025-03-272025-03-31732$72.64 $53.2K577,076SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2025-03-272025-03-314,782$71.74 $343.1K577,808SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2025-03-272025-03-313,291$70.73 $232.8K582,590SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2025-03-272025-03-3131,980$69.84 $2.23M585,881SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2025-03-272025-03-3114,183$65.97 $935.7K738,179SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2025-03-272025-03-3141,989$67.70 $2.84M673,095SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-03-272025-03-311,418$65.97 $93.5K110,884SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-03-272025-03-313,198$69.84 $223.3K95,653SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-03-272025-03-312,310$66.79 $154.3K108,574SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-03-272025-03-3115,145$72.50 $1.10M55,789SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-03-272025-03-3124,989$70.18 $1.75M70,934SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-03-272025-03-3124,776$67.47 $1.67M95,923SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-03-272025-03-3146,214$66.39 $3.07M120,699SEC↗
Hirano Patricia CSEE REMARKS M Exercise2025-03-272025-03-3135,186$5.25 $184.7K166,913SEC↗
Hirano Patricia CSEE REMARKS M Exercise2025-03-272025-03-318,333$2.41 $20.1K131,727SEC↗
Hirano Patricia CSEE REMARKS M Exercise2025-03-272025-03-3113,333$2.60 $34.7K123,394SEC↗
Hirano Patricia CSEE REMARKS M Exercise2025-03-272025-03-314,888$5.10 $24.9K110,061SEC↗
Hirano Patricia CSEE REMARKS M Exercise2025-03-272025-03-314,400$25.05 $110.2K105,173SEC↗
Hirano Patricia CSEE REMARKS M Exercise2025-03-272025-03-316,000$24.00 $144.0K100,773SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-03-272025-03-3173$72.64 $5.3K94,773SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-03-272025-03-31478$71.74 $34.3K94,846SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-03-272025-03-31329$70.73 $23.3K95,324SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-03-272025-03-314,199$67.70 $284.3K104,375SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-03-272025-03-315,524$68.79 $380.0K98,851SEC↗
Huang Michael F.Sr. VP of Clinical Developme S Sale2025-03-272025-03-31371$65.97 $24.5K41,029SEC↗
Huang Michael F.Sr. VP of Clinical Developme S Sale2025-03-272025-03-3110,000$70.03 $700.3K36,817SEC↗
Huang Michael F.Sr. VP of Clinical Developme M Exercise2025-03-272025-03-3110,000$21.93 $219.3K46,817SEC↗
Huang Michael F.Sr. VP of Clinical Developme S Sale2025-03-272025-03-3119$72.64 $1.4K36,817SEC↗
Huang Michael F.Sr. VP of Clinical Developme S Sale2025-03-272025-03-31125$71.74 $9.0K36,836SEC↗
Huang Michael F.Sr. VP of Clinical Developme S Sale2025-03-272025-03-3186$70.73 $6.1K36,961SEC↗
Huang Michael F.Sr. VP of Clinical Developme S Sale2025-03-272025-03-31836$69.84 $58.4K37,047SEC↗
Huang Michael F.Sr. VP of Clinical Developme S Sale2025-03-272025-03-311,444$68.79 $99.3K37,883SEC↗
Huang Michael F.Sr. VP of Clinical Developme S Sale2025-03-272025-03-311,098$67.70 $74.3K39,327SEC↗
Huang Michael F.Sr. VP of Clinical Developme S Sale2025-03-272025-03-31604$66.79 $40.3K40,425SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER M Exercise2025-03-272025-03-3120,000$30.75 $615.0K125,176SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2025-03-272025-03-31387$70.73 $27.4K105,825SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2025-03-272025-03-313,762$69.84 $262.7K106,212SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2025-03-272025-03-316,498$68.79 $447.0K109,974SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2025-03-272025-03-314,940$67.70 $334.4K116,472SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2025-03-272025-03-312,717$66.79 $181.5K121,412SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2025-03-272025-03-311,669$65.97 $110.1K124,129SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2025-03-272025-03-318,044$70.80 $569.5K105,176SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2025-03-272025-03-3136,157$70.03 $2.53M113,220SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2025-03-272025-03-3125,799$69.07 $1.78M149,377SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER M Exercise2025-03-272025-03-3120,000$5.25 $105.0K175,176SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER M Exercise2025-03-272025-03-3115,000$2.41 $36.1K155,176SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER M Exercise2025-03-272025-03-315,000$2.60 $13.0K140,176SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER M Exercise2025-03-272025-03-3110,000$5.10 $51.0K135,176SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2025-03-272025-03-31563$71.74 $40.4K105,262SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2025-03-272025-03-3186$72.64 $6.2K105,176SEC↗
Manning MeredithChief Commercial Officer S Sale2025-03-272025-03-3137,000$67.04 $2.48M45,351SEC↗
Manning MeredithChief Commercial Officer S Sale2025-03-272025-03-31668$65.97 $44.1K52,932SEC↗
Manning MeredithChief Commercial Officer S Sale2025-03-272025-03-311,087$66.79 $72.6K51,845SEC↗
Manning MeredithChief Commercial Officer S Sale2025-03-272025-03-311,976$67.70 $133.8K49,869SEC↗
Manning MeredithChief Commercial Officer S Sale2025-03-272025-03-312,599$68.79 $178.8K47,270SEC↗
Manning MeredithChief Commercial Officer S Sale2025-03-272025-03-311,505$69.84 $105.1K45,765SEC↗
Manning MeredithChief Commercial Officer S Sale2025-03-272025-03-31155$70.73 $11.0K45,610SEC↗
Manning MeredithChief Commercial Officer S Sale2025-03-272025-03-31225$71.74 $16.1K45,385SEC↗
Manning MeredithChief Commercial Officer S Sale2025-03-272025-03-3134$72.64 $2.5K45,351SEC↗
Manning MeredithChief Commercial Officer M Exercise2025-03-272025-03-3137,000$46.31 $1.71M82,351SEC↗
Yen KristenSEE REMARKS S Sale2025-03-272025-03-315,239$67.70 $354.7K73,116SEC↗
Yen KristenSEE REMARKS S Sale2025-03-272025-03-3150,156$66.00 $3.31M51,618SEC↗
Yen KristenSEE REMARKS S Sale2025-03-272025-03-31411$70.73 $29.1K61,824SEC↗
Yen KristenSEE REMARKS S Sale2025-03-272025-03-31597$71.74 $42.8K61,227SEC↗
Yen KristenSEE REMARKS S Sale2025-03-272025-03-313,990$69.84 $278.7K62,235SEC↗
Yen KristenSEE REMARKS S Sale2025-03-272025-03-316,891$68.79 $474.0K66,225SEC↗
Yen KristenSEE REMARKS S Sale2025-03-272025-03-3123,475$66.95 $1.57M28,143SEC↗
Yen KristenSEE REMARKS S Sale2025-03-272025-03-312,881$66.79 $192.4K78,355SEC↗
Yen KristenSEE REMARKS S Sale2025-03-272025-03-311,769$65.97 $116.7K81,236SEC↗
Yen KristenSEE REMARKS M Exercise2025-03-272025-03-314,888$5.10 $24.9K66,024SEC↗
Yen KristenSEE REMARKS S Sale2025-03-272025-03-3191$72.64 $6.6K61,136SEC↗
Yen KristenSEE REMARKS M Exercise2025-03-272025-03-313,750$2.41 $9.0K69,774SEC↗
Yen KristenSEE REMARKS M Exercise2025-03-272025-03-3132,000$5.25 $168.0K101,774SEC↗
Vivo Opportunity Fund Holdings10% Owner S Sale2025-03-262025-03-28400,000$65.80 $26.32M5,891,851SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER A Award deriv2025-01-212025-01-23115,600— $0115,600SEC↗
Hirano Patricia CSEE REMARKS A Award deriv2025-01-212025-01-2313,800— $013,800SEC↗
Huang Michael F.Sr. VP of Clinical Developme A Award deriv2025-01-212025-01-2313,800— $013,800SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER A Award deriv2025-01-212025-01-2331,000— $031,000SEC↗
Manning MeredithChief Commercial Officer A Award deriv2025-01-212025-01-2329,200— $029,200SEC↗
Yen KristenSEE REMARKS A Award deriv2025-01-212025-01-2313,800— $013,800SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER A Award2025-01-212025-01-2353,900— $0752,362SEC↗
Hirano Patricia CSEE REMARKS A Award2025-01-212025-01-236,400— $0112,302SEC↗
Huang Michael F.Sr. VP of Clinical Developme A Award2025-01-212025-01-236,400— $041,400SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER A Award2025-01-212025-01-2314,500— $0125,798SEC↗
Manning MeredithChief Commercial Officer A Award2025-01-212025-01-2313,600— $053,600SEC↗
Yen KristenSEE REMARKS A Award2025-01-212025-01-236,400— $083,005SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2025-01-032025-01-0610,154$46.18 $468.9K698,462SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-01-032025-01-061,459$46.18 $67.4K105,902SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2025-01-032025-01-063,791$46.18 $175.1K111,298SEC↗
Yen KristenSEE REMARKS S Sale2025-01-032025-01-062,340$46.18 $108.1K76,605SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2025-01-022025-01-0610,077$45.37 $457.2K709,476SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2025-01-022025-01-06860$45.92 $39.5K708,616SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-01-022025-01-061,447$45.37 $65.7K107,485SEC↗
Hirano Patricia CSEE REMARKS S Sale2025-01-022025-01-06124$45.92 $5.7K107,361SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2025-01-022025-01-063,762$45.37 $170.7K115,410SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2025-01-022025-01-06321$45.92 $14.7K115,089SEC↗
Yen KristenSEE REMARKS S Sale2025-01-022025-01-06198$45.92 $9.1K78,945SEC↗
Yen KristenSEE REMARKS S Sale2025-01-022025-01-062,322$45.37 $105.3K79,143SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2024-10-012024-10-0319,413$49.34 $957.8K721,773SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2024-10-012024-10-032,220$50.25 $111.6K719,553SEC↗
Hirano Patricia CSEE REMARKS S Sale2024-10-012024-10-032,789$49.34 $137.6K109,251SEC↗
Hirano Patricia CSEE REMARKS S Sale2024-10-012024-10-03319$50.25 $16.0K108,932SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2024-10-012024-10-037,248$49.34 $357.6K120,001SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2024-10-012024-10-03829$50.25 $41.7K119,172SEC↗
Yen KristenSEE REMARKS S Sale2024-10-012024-10-03319$50.25 $16.0K81,465SEC↗
Yen KristenSEE REMARKS S Sale2024-10-012024-10-032,789$49.34 $137.6K81,784SEC↗
Vivo Opportunity, LLC10% Owner S Sale2024-08-292024-08-29100,000$47.22 $4.72M6,291,851SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2024-08-292024-08-3047,551$47.16 $2.24M752,026SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2024-08-292024-08-3010,840$47.83 $518.5K741,186SEC↗
Hirano Patricia CSEE REMARKS S Sale2024-08-292024-08-304,426$47.16 $208.7K113,049SEC↗
Hirano Patricia CSEE REMARKS S Sale2024-08-292024-08-301,009$47.83 $48.3K112,040SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2024-08-292024-08-301,275$47.83 $61.0K127,249SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2024-08-292024-08-305,595$47.16 $263.9K128,524SEC↗
Yen KristenSEE REMARKS S Sale2024-08-292024-08-304,426$47.16 $208.7K85,582SEC↗
Yen KristenSEE REMARKS S Sale2024-08-292024-08-301,009$47.83 $48.3K84,573SEC↗
Vivo Opportunity, LLC10% Owner S Sale2024-08-282024-08-29425,000$47.35 $20.12M6,391,851SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2024-08-282024-08-3030,262$47.19 $1.43M825,928SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2024-08-282024-08-3026,351$48.03 $1.27M799,577SEC↗
Hirano Patricia CSEE REMARKS S Sale2024-08-282024-08-302,453$48.03 $117.8K117,475SEC↗
Hirano Patricia CSEE REMARKS S Sale2024-08-282024-08-302,817$47.19 $132.9K119,928SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2024-08-282024-08-303,100$48.03 $148.9K134,119SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2024-08-282024-08-303,561$47.19 $168.0K137,219SEC↗
Yen KristenSEE REMARKS S Sale2024-08-282024-08-302,453$48.03 $117.8K90,008SEC↗
Yen KristenSEE REMARKS S Sale2024-08-282024-08-302,817$47.19 $132.9K92,461SEC↗
Vivo Opportunity, LLC10% Owner S Sale2024-08-272024-08-29500,000$48.73 $24.36M6,816,851SEC↗
Bir Dawn CarterDirector A Award2024-08-152024-08-1613,000— $013,000SEC↗
Urbanski Raymond W.CHIEF DEVELOPMENT OFFICER A Award deriv2024-08-132024-08-23145,000— $0145,000SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2024-08-062024-08-076,789$43.64 $296.3K918,532SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2024-08-062024-08-0722,937$45.25 $1.04M895,595SEC↗
Anish BhatnagarCHIEF EXECUTIVE OFFICER S Sale2024-08-062024-08-0739,405$45.89 $1.81M856,190SEC↗
Hirano Patricia CSEE REMARKS S Sale2024-08-062024-08-07587$43.64 $25.6K128,135SEC↗
Hirano Patricia CSEE REMARKS S Sale2024-08-062024-08-073,407$45.89 $156.3K122,745SEC↗
Hirano Patricia CSEE REMARKS S Sale2024-08-062024-08-071,983$45.25 $89.7K126,152SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2024-08-062024-08-072,699$45.25 $122.1K145,416SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2024-08-062024-08-074,636$45.89 $212.7K140,780SEC↗
Mackaness James HCHIEF FINANCIAL OFFICER S Sale2024-08-062024-08-07799$43.64 $34.9K148,115SEC↗
Yen KristenSEE REMARKS S Sale2024-08-062024-08-07585$43.64 $25.5K100,650SEC↗
Yen KristenSEE REMARKS S Sale2024-08-062024-08-071,976$45.25 $89.4K98,674SEC↗